Abstract
Aim:
To determine the release characteristics of a 5-fluorouracil-loaded poly (lactic acid) disc (5-FU-PLA-DS) and the effect of sustained drug delivery on the success of glaucoma filtration surgery in rabbit eyes.
Methods:
A method of microspheres accumulated by excessive carriers was used in the preparation of the 5-FU-PLA-DS. The disc was characterized for drug loading, entrapment efficiency, in vitro release, and external morphology. It was then implanted subconjunctivally into rabbit eyes with trabeculectomy. Intraocular pressure, ocular inflammatory reaction, filtration bleb appearance, and persistence were evaluated up to postoperative d 90. A quantitative analysis of 5-fluorouracil (5-FU) was performed in the aqueous humor. Ultrasound biomicroscopy was used to assess the appearance of the filtering fistula.
Results:
The 5-FU-PLA-DS was produced with the drug-loading of 3.07±0.08 mg (mean±SD). 5-FU was released for 91 d with suppressive concentrations. The decrease in intraocular pressure from baseline was significantly more marked in the 5-FU-PLA-DS-implanted eyes during postoperative d 3-90, and the persistence of bleb and filtration fistula was longer than the control eyes (P<0.05). Corneal toxicity and hyperemia triggered by 5-FU was lower in the 5-FU-PLA-DS-implanted eyes than those exposed to 5-FU intraoperatively. The 5-FU concentration in the aqueous humor was insufficient for corneal endothelial damage. No evidence of toxic reaction was found in the conjunctival biopsy.
Conclusion:
5-FU-PLA-DS displaying sustained intraocular release of 5-FU, reduced intraocular pressure, and prolonged bleb persistence, while significantly reducing 5-FU toxicity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Collignon NJ . Wound healing after glaucoma surgery: how to manage it? Bull Soc Belge Ophtalmol 2005; 295: 55–9.
Lama PJ, Fechtner RD . Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003; 48: 314–46.
Tahery MM, Lee DA . Pharmacologic control of wound healing in glaucoma filtration surgery. J Ocul Pharmacol 1989; 5: 155–79.
The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol 1996; 121: 349–66.
Joshi AB, Parrish RK 2nd, Feuer WF . 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 2005; 14: 172–4.
Abraham LM, Selva D, Casson R, Leibovitch I . The clinical applications of fluorouracil in ophthalmic practice. Drugs 2007; 67: 237–55.
Sisto D, Vetrugno M, Trabucco T, Cantatore F, Ruggeri G, Sborgia C . The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Acta Ophthalmol Scand 2007; 85: 267–71.
Fraser S . Trabeculectomy and antimetabolites. Br J Ophthalmol 2004; 88: 855–6.
Elorza B, Elorza MA, Frutos G, Chantres JR . Characterization of 5-fluorouracil loaded liposomes prepared by reverse-phase evaporation or freezing-thawing extrusion methods: study of drug release. Biochim Biophys Acta 1993; 1153: 135–42.
Hitzman CJ, Elmquist WF, Wattenberg LW, Wiedmann TS . Development of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles. J Pharm Sci 2006; 95: 1114–26.
Aksungur P, Sungur A, Unal S, Iskit AB, Squier CA, Senel S . Chito-san delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J Control Release 2004; 98: 269–79.
Gao H, Gu Y, Ping Q . The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension. J Control Release 2007; 118: 325–32.
Pandey SK, Cochener B, Apple DJ, Colin J, Werner L, Bougaran R, et al. Intracapsular ring sustained 5-fluorouracil delivery system for the prevention of posterior capsule opacification in rabbits: a histo-logical study. J Cataract Refract Surg 2002; 28: 139–48.
Sastre RL, Olmo R, Teijón C, Muñiz E, Teijón JM, Blanco MD . 5-Fluorouracil plasma levels and biodegradation of subcutane-ously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Int J Pharm 2007; 338: 180–90.
Moritera T, Ogura Y, Honda Y, Wada R, Hyon SH, Ikada Y . Micro-spheres of biodegradable polymers as a drug-delivery system in the vitreous. Invest Ophthalmol Vis Sci 1991; 32: 1785–90.
Huang KH, Zhu ZH, Liu JH, Chen QK, Liu XY, Chang J . Preparation and release efficiency of polylactic acid nanoparticle. Ai Zheng 2005; 24: 1023–6.
Blandford DL, Smith TJ, Brown JD, Pearson PA, Ashton P . Subcon-junctival sustained release 5-fluorouracil. Invest Ophthalmol Vis Sci 1992; 33: 3430–5.
Lee DA, Leong KW, Panek WC, Eng CT, Glasgow BJ . The use of bioerodible polymer and 5-fluorouracil in glaucoma filtering surgery. Invest Ophthalmol Vis Sci 1988; 29: 1692–7.
Einmahl S, Behar-Cohen F, D'Hermies F, Rudaz S, Tabatabay C, Re-nard G, et al. A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery. Invest Ophthalmol Vis Sci 2001; 42: 695–700.
Heller J . Ocular delivery using poly(ortho esters). Adv Drug Deliv Rev 2005; 57: 2053–62.
Jampel HD, Leong KW, Dunkelburger GR, Quigley HA . Glaucoma filtration surgery in monkeys using 5-fluorouridine in polyanhydride discs. Arch Ophthalmol 1990; 108: 430–5.
Hasty B, Heuer DK, Minckler DS . Primate trabeculectomies with 5-fluorouracil collagen implants. Am J Ophthalmol 1990; 109: 721–5.
Lee DA, Shapourifar TS, Kitada S . The effect of 5-fluorouracil and cytarabine on human fibroblasts from Tenon's capsule. Invest Ophthalmol Vis Sci 1990; 31: 1848–55.
Khaw PT, Word S, Porter A, Grierson I, Hitchings RA, Rice NSC . The long-term effects of 5-fluorourocil and sodium butyrate on human tenon's fibroblasts. Invest Ophthalmol Vis Sci 1992; 33: 2043–52.
Mannis MJ, Sweet EH, Lewis RA . The effect of fluorouracil on the corneal endothelium. Arch Ophthalmol 1988; 106: 816–7.
Wilkins MR, Occleston NL, Kotecha A, Waters L, Khaw PT . Sponge delivery variables and tissue levels of 5-fluorouracil. Br J Ophthalmol 2000; 84: 92–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by the 2006 Science and Technology Program of Shanxi Province [No2006K11-G6(1)].
Rights and permissions
About this article
Cite this article
Cui, Lj., Sun, Nx., Li, Xh. et al. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery. Acta Pharmacol Sin 29, 1021–1028 (2008). https://doi.org/10.1111/j.1745-7254.2008.00833.x
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00833.x
Keywords
This article is cited by
-
Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Advances in Therapy (2017)
-
Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery
Acta Pharmacologica Sinica (2009)
